Geller Advisors’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
$597K Sell
2,509
-21
-0.8% -$4.83K 0.04% 113
2024
Q3
$558K Buy
2,530
+22
+0.9% +$4.55K 0.04% 124
2024
Q2
$493K Sell
2,508
-17
-0.7% -$3.51K 0.04% 144
2024
Q1
$544K Buy
2,525
+161
+7% +$33.8K 0.04% 128
2023
Q4
$510K Buy
2,364
+84
+4% +$17.9K 0.05% 121
2023
Q3
$457K Buy
2,280
+1,024
+82% +$204K 0.05% 126
2023
Q2
$233K Buy
+1,256
New +$232K 0.03% 224
2022
Q3
Sell
-1,086
Closed -$222K 137
2022
Q2
$222K Buy
1,086
+5
+0.5% +$1.06K 0.05% 122
2022
Q1
$257K Sell
1,081
-4
-0.4% -$939 0.05% 128
2021
Q4
$251K Sell
1,085
-4
-0.4% -$880 0.05% 137
2021
Q3
$211K Buy
1,089
+84
+8% +$17K 0.05% 150
2021
Q2
$214K Buy
1,005
+6
+0.6% +$1.27K 0.05% 126
2021
Q1
$204K Buy
+999
New +$197K 0.05% 120

Other funds holding CME

Geller Advisors's CME Position: Q4 2024 in Review

Geller Advisors reduced its CME Group (CME) stake by 0.83% in Q4 2024, selling an estimated $4.83K and leaving 2,509 shares worth $597K. The position accounts for 0.04% of the portfolio, ranked #113.

Geller Advisors first reported a position in CME in Q1 2021 and has held it in 13 quarters since. 1,500 funds tracked by Wall St. Rank hold CME as of Q4 2024.

  • Geller Advisors held 2,509 shares of CME Group worth $597K as of Q4 2024.
  • Geller Advisors sold 21 CME Group shares in Q4 2024, an estimated $4.83K.
  • CME Group made up 0.04% of Geller Advisors's portfolio in Q4 2024, its #113 holding.
  • Geller Advisors first reported a position in CME Group in Q1 2021 and has held it in 13 quarters since.
  • 1,500 funds tracked by Wall St. Rank held CME Group as of Q4 2024.

Based on Geller Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.